A carregar...
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
Vandetanib (ZD6474) is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors, including RET (Rearrange during transfection), vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR). The activity against RET and...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3153121/ https://ncbi.nlm.nih.gov/pubmed/21836817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S6197 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|